A new MRI technique, called “chemical shift,” can help identify the smallest presence of fat. The presence of fat helps differentiate between clear cell renal cell carcinoma and other types of renal cancer. Renal cell carcinoma, or hypernephroma, originates in the proximal convoluted tubule lining. It is the most common kidney cancer (about 80% of cases), and also the most lethal of all genitourinary tumors (genital and urinary-related).
This cancer has the greatest potential to metastasize, which is what makes it so lethal. The five-year survival rate is 60-70% before metastases have spread.
Dr. Azadeh Elmi from Massachusetts General Hospital in Boston found that MRI scans were 83% accurate in identifying clear cell renal cell carcinoma. This detection is a less-invasive way to properly identify and conquer cancer. The more a doctor knows about what he or she is dealing with, the more refined the treatments can be.
To read more about the study, you can read the article here.
To learn more about Rosetta Radiology’s Radiation-Oncology Unit, click here.